2026-08-11
Publication of Updated NordicAST Clinical Breakpoint tables, version 16.1.
Updated versions (16.1) of the NordicAST clinical breakpoint tables have now been published, including breakpoints for additional anaerobic bacteri...
New extended BMD panel for staphylococci and enterococci at EDL
Published at 2019.03.26
EDL offers BMD according to ISO 20776-1 for clinical isolates (external page).
From March 2019, we offer an additional panel for staphylococci and enterococci. The panel contains the following antimicrobial agents: ceftaroline, dalbavancin, oritavancin, telavancin, vancomycin, erythromycin, clindamycin, linezolid and tedizolid.
Related articles
2026-07-15
NordicAST Project Grants
NordicAST launches NordicAST grants to support studies initiated and conducted by employees in Nordic clinical microbiology laboratories which are ...
2026-07-15
Publication of Updated EUCAST Clinical Breakpoint tables, version 16.1.
An updated version (16.1) of the EUCAST clinical breakpoint tables has been published, including breakpoints for additional anaerobic bacterial spe...